The percent concordances of the results of IgM assays compared with nucleic acid amplification testing (NAT)-confirmed recent infection and specificity were highly variable, ranging from 55.8 to 99.5% and 34.3 to 99.0%, respectively. The gene discussed is CD40LG; the disease is infection.